04/25/2025
3:31 PM | Axsome Therapeutics (Filer)
| Form DEF 14A | |
04/25/2025
3:32 PM | Axsome Therapeutics (Filer)
| Form DEFA14A | |
04/25/2025
3:33 PM | Axsome Therapeutics (Filer)
| Form ARS | |
04/01/2025
6:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2025
6:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/03/2025
6:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2025
6:56 PM | Axsome Therapeutics (Issuer)
Murdock Hunter R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
6:57 PM | Axsome Therapeutics (Issuer)
Maizel Ari (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
6:59 PM | Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
7:00 PM | Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for AXSM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Axsome Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/25/2025
7:02 PM | Axsome Therapeutics (Issuer)
Mahony Susan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
6:51 PM | Axsome Therapeutics (Issuer)
TABUTEAU HERRIOT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
6:53 PM | Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
6:54 PM | Axsome Therapeutics (Issuer)
Pizzie Nick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
6:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
8:20 PM | Axsome Therapeutics (Issuer)
Pizzie Nick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
8:00 AM | Axsome Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025
6:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
6:56 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
8:43 AM | Axsome Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/24/2024
5:23 PM | Axsome Therapeutics (Issuer)
Maizel Ari (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/01/2024
4:24 PM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
6:00 PM | Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:32 PM | Axsome Therapeutics (Subject)
Saad Mark E (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2024
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
6:27 PM | Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
3:30 PM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
3:30 PM | Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:31 PM | Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:31 PM | Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:32 PM | Axsome Therapeutics (Issuer)
Mahony Susan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
6:38 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
7:11 PM | Axsome Therapeutics (Issuer)
Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
7:12 PM | Axsome Therapeutics (Issuer)
Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:28 PM | Axsome Therapeutics (Subject)
Coleman Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/06/2024
4:20 PM | Axsome Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Is he more powerful than Trump? (Ad) Is there anybody more powerful than Donald Trump right now?
In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones…
Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move. Whether you take some of that wealth for yourself depends on if you watch this controversial exposé |
05/06/2024
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
